Paola Portillo-Sánchez

Author

Malcom Randall VA Medical Center ORCID

Also Known As

P Portillo-Sanchez, Paola Portillo-Sanchez, Paola Portillo-Sánchez, Paola Portillo‐Sanchez

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Malcom Randall VA Medical Center University of Florida The University of Texas Health Science Center at San Antonio Murphy Oil Corporation (United States)

About

Paola Portillo-Sánchez is an author at Malcom Randall VA Medical Center specializing in metabolic associated steatotic liver disease, diabetes, and nonalcoholic fatty liver disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	634
2	Medicine	3	3	634
3	Diabetes	3	3	634
4	Hepatology	3	3	634
5	Epidemiology	1	1	498

Paola Portillo-Sánchez

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus Kenneth Cusi, Beverly Orsak, Fernando Bril, Annals of Internal Medicine	2016	957
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels Paola Portillo-Sánchez, Fernando Bril, Maryann Maximos, The Journal of Clinical Endocrinology & Metabolism Metabolic DisorderPathologyFatty Liver DiseaseObesityMetabolic Syndrome	2015	498
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease Fernando Bril, Diana Barb, Paola Portillo-Sánchez, Hepatology	2016	280
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes Romina Lomonaco, Fernando Bril, Paola Portillo-Sánchez, Diabetes Care	2016	147
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis Fernando Bril, Maryann Maximos, Paola Portillo-Sánchez, Journal of Hepatology Insulin ResistanceNutritionMetabolic SyndromeMetabolic Associated SteatohepatitisObesity	2014	119
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients Fernando Bril, Paola Portillo-Sánchez, I‐Chia Liu, Diabetes Care	2017	44
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36‐month clinical trial Paola Portillo-Sánchez, Fernando Bril, Romina Lomonaco, Journal of Diabetes	2018	41
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus Kenneth Cusi, Beverly Orsak, Fernando Bril, Annals of Internal Medicine Metabolic DisorderPathologyPharmacotherapyFatty Liver DiseaseObesity	2016	17

Page 1